$57.79
1.29[2.28%]
At close: Apr 26
Lonza Group
(OTCPK:LZAGY)Latest News for Lonza Group Stock (OTC:LZAGY)
Lonza Group Stock (OTC: LZAGY)
Categories: All
Wednesday, March 20, 2024
Wednesday, June 22, 2022
Wednesday, June 02, 2021
Thursday, April 29, 2021
Wednesday, April 14, 2021
Friday, March 12, 2021
Tuesday, February 23, 2021
Tuesday, November 10, 2020
Sunday, July 26, 2020
Tuesday, March 24, 2020
Thursday, February 13, 2020
Wednesday, February 12, 2020
Tuesday, February 11, 2020
Wednesday, January 22, 2020
Tuesday, January 21, 2020
Thursday, January 16, 2020
Thursday, October 17, 2019
- The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPOShanthi Rexaline - Oct 17, 2019, 7:39AM
- Mesoblast, Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast's Potential First United States Allogeneic Cell TherapyCharles Gross - Oct 17, 2019, 4:08AM
Tuesday, October 08, 2019
- The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy CollaborationShanthi Rexaline - Oct 8, 2019, 7:11AM
- Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative DiseasesCharles Gross - Oct 8, 2019, 4:25AM